Cargando…

De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy

De novo variants are increasingly recognized as a common cause of early infantile epileptic encephalopathies. We present a 4-yr-old male with epileptic encephalopathy characterized by seizures, autism spectrum disorder, and global developmental delay. Whole-genome sequencing of the proband and his u...

Descripción completa

Detalles Bibliográficos
Autores principales: Latsko, Maeson S., Koboldt, Daniel C., Franklin, Samuel J., Hickey, Scott E., Williamson, Rachel K., Garner, Shannon, Ostendorf, Adam P., Lee, Kristy, White, Peter, Wilson, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235849/
https://www.ncbi.nlm.nih.gov/pubmed/35534222
http://dx.doi.org/10.1101/mcs.a006172
_version_ 1784736407666819072
author Latsko, Maeson S.
Koboldt, Daniel C.
Franklin, Samuel J.
Hickey, Scott E.
Williamson, Rachel K.
Garner, Shannon
Ostendorf, Adam P.
Lee, Kristy
White, Peter
Wilson, Richard K.
author_facet Latsko, Maeson S.
Koboldt, Daniel C.
Franklin, Samuel J.
Hickey, Scott E.
Williamson, Rachel K.
Garner, Shannon
Ostendorf, Adam P.
Lee, Kristy
White, Peter
Wilson, Richard K.
author_sort Latsko, Maeson S.
collection PubMed
description De novo variants are increasingly recognized as a common cause of early infantile epileptic encephalopathies. We present a 4-yr-old male with epileptic encephalopathy characterized by seizures, autism spectrum disorder, and global developmental delay. Whole-genome sequencing of the proband and his unaffected parents revealed a novel de novo missense variant in GRIA2 (c.1589A > T; p.Lys530Met; ENST00000264426.14). Variants in the GRIA2 gene were recently reported to cause an autosomal dominant neurodevelopmental disorder with language impairments and behavioral abnormalities (OMIM; MIM #618917), a condition characterized by intellectual disability and developmental delay in which seizures are a common feature. The de novo variant identified in our patient maps to the edge of a key ligand binding domain of the AMPA receptor and has not been previously reported in gnomAD or other public databases, making it novel. Our findings provided a long-sought diagnosis for this patient and support the link between GRIA2 and a dominant neurodevelopmental disorder.
format Online
Article
Text
id pubmed-9235849
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-92358492022-07-08 De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy Latsko, Maeson S. Koboldt, Daniel C. Franklin, Samuel J. Hickey, Scott E. Williamson, Rachel K. Garner, Shannon Ostendorf, Adam P. Lee, Kristy White, Peter Wilson, Richard K. Cold Spring Harb Mol Case Stud Rapid Communication De novo variants are increasingly recognized as a common cause of early infantile epileptic encephalopathies. We present a 4-yr-old male with epileptic encephalopathy characterized by seizures, autism spectrum disorder, and global developmental delay. Whole-genome sequencing of the proband and his unaffected parents revealed a novel de novo missense variant in GRIA2 (c.1589A > T; p.Lys530Met; ENST00000264426.14). Variants in the GRIA2 gene were recently reported to cause an autosomal dominant neurodevelopmental disorder with language impairments and behavioral abnormalities (OMIM; MIM #618917), a condition characterized by intellectual disability and developmental delay in which seizures are a common feature. The de novo variant identified in our patient maps to the edge of a key ligand binding domain of the AMPA receptor and has not been previously reported in gnomAD or other public databases, making it novel. Our findings provided a long-sought diagnosis for this patient and support the link between GRIA2 and a dominant neurodevelopmental disorder. Cold Spring Harbor Laboratory Press 2022-06 /pmc/articles/PMC9235849/ /pubmed/35534222 http://dx.doi.org/10.1101/mcs.a006172 Text en © 2022 Latsko et al.; Published by Cold Spring Harbor Laboratory Press https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.
spellingShingle Rapid Communication
Latsko, Maeson S.
Koboldt, Daniel C.
Franklin, Samuel J.
Hickey, Scott E.
Williamson, Rachel K.
Garner, Shannon
Ostendorf, Adam P.
Lee, Kristy
White, Peter
Wilson, Richard K.
De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
title De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
title_full De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
title_fullStr De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
title_full_unstemmed De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
title_short De novo missense variant in GRIA2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
title_sort de novo missense variant in gria2 in a patient with global developmental delay, autism spectrum disorder, and epileptic encephalopathy
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235849/
https://www.ncbi.nlm.nih.gov/pubmed/35534222
http://dx.doi.org/10.1101/mcs.a006172
work_keys_str_mv AT latskomaesons denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT koboldtdanielc denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT franklinsamuelj denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT hickeyscotte denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT williamsonrachelk denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT garnershannon denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT ostendorfadamp denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT leekristy denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT whitepeter denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy
AT wilsonrichardk denovomissensevariantingria2inapatientwithglobaldevelopmentaldelayautismspectrumdisorderandepilepticencephalopathy